home / news releases


PR Newswire News Releases and Press Releases From 07/22/24

Now Trending

Company Name:Immutep Limited
Stock Symbol:IMMP
Market:NASDAQ
Website:immutep.com

Menu

IMMP IMMP Quote IMMP Short IMMP News IMMP Articles IMMP Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

IONS - Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome

Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome PR Newswire ION582 showed robust and consistent benefit in communication, cognition and motor function in a broad patient population evaluated with a comprehensive set o...

DQ - Daqo New Energy Announces $100 Million Share Repurchase Program

Daqo New Energy Announces $100 Million Share Repurchase Program PR Newswire SHANGHAI , July 22, 2024 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global sola...

PNM - PNM Resources (NYSE: PNM) Transitions to TXNM Energy (NYSE: TXNM) with Trading Effective on August 5

PNM Resources (NYSE: PNM) Transitions to TXNM Energy (NYSE: TXNM) with Trading Effective on August 5 PR Newswire ALBUQUERQUE, N.M. , July 22, 2024 /PRNewswire/ -- PNM Resources, Inc. (NYSE: PNM) is expecting to complete the change of its holding company name to T...

RTX - RTX completes preliminary design review of hybrid-electric Pratt & Whitney GTF(TM) engine demonstrator for Clean Aviation SWITCH project

RTX completes preliminary design review of hybrid-electric Pratt & Whitney GTF™ engine demonstrator for Clean Aviation SWITCH project RTX completes preliminary design review of hybrid-electric Pratt & Whitney GTF™ engine demonstrator for Clean Aviation SWITCH proje...

NUVL - Nuvalent Announces First Patient Dosed in HEROEX-1 Phase 1a/1b Clinical Trial of NVL-330, its Novel HER2-selective Inhibitor

Nuvalent Announces First Patient Dosed in HEROEX-1 Phase 1a/1b Clinical Trial of NVL-330, its Novel HER2-selective Inhibitor PR Newswire CAMBRIDGE, Mass. , July 22, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company foc...

BA - Korean Air Commits to Up to 50 Boeing Widebodies to Strengthen Future Long-Haul Fleet

Korean Air Commits to Up to 50 Boeing Widebodies to Strengthen Future Long-Haul Fleet - Korea's flag carrier to become newest 777X customer with commitment for 20 777-9 passenger airplanes - Order for up to 30 787-10 jets will nearly double airline's 787 Dreamliner order book ahead ...

TMHC - Taylor Morrison to Serve as the Exclusive Homebuilder for Extreme Makeover: Home Edition

Taylor Morrison to Serve as the Exclusive Homebuilder for Extreme Makeover: Home Edition PR Newswire America's Most Trusted® Home Builder to build brand-new homes for deserving families in ABC reboot SCOTTSDALE, Ariz. , July 22, 2024 /PRNewswire/ --&...

KBR - KBR's Blue Ammonia Technology Selected for Shell Blue Horizons Project in Oman

KBR's Blue Ammonia Technology Selected for Shell Blue Horizons Project in Oman PR Newswire HOUSTON , July 22, 2024 /PRNewswire/ -- KBR (NYSE: KBR) announced today its blue ammonia technology has been selected by Shell for its Blue Horizons low-carbon hydrogen and...

TBPH - Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024

Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 PR Newswire DUBLIN , July 22, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2024 financial results and provide a business update...

BA - National Airlines Selects Four Boeing 777 Freighters to Expand Global Fleet

National Airlines Selects Four Boeing 777 Freighters to Expand Global Fleet - World's most capable twin-engine freighter provides market-leading range and reliability to meet global air cargo demand PR Newswire FARNBOROUGH, United Kingdom , July 22, 2024 /PRN...

Previous 10 Next 10